Public Profile

Doc Generici

Doc Generici, officially known as Doc Generici S.p.A., is a prominent player in the pharmaceutical industry, headquartered in Italy. Established in 2000, the company has rapidly expanded its operations across major regions in Europe, focusing on the development and distribution of generic medicines. Specialising in high-quality generics, Doc Generici offers a diverse portfolio of products that stand out for their efficacy and affordability. The company is committed to innovation and sustainability, ensuring that its offerings meet rigorous regulatory standards while addressing the needs of healthcare providers and patients alike. With a strong market position, Doc Generici has achieved notable milestones, including significant partnerships and a growing presence in the European market, solidifying its reputation as a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does Doc Generici's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Doc Generici's score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Doc Generici's reported carbon emissions

Doc Generici, headquartered in Italy, currently does not have available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of defined initiatives, it is essential for Doc Generici to establish measurable climate commitments and reduction strategies to align with industry standards and contribute positively to global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Doc Generici's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Doc Generici is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Doc Generici is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers